pharmaceutical investing Innovation Pharmaceuticals Signs Drug Supply Contract with Evonik to Bulk Produce Commercial-Grade Brilacidin
pharmaceutical investing Innovation Pharmaceuticals Data from Phase 2 Brilacidin Oral Mucositis (OM) Trial in Head and Neck Cancer Show Notable Reductions in Median Duration of Severe OM
Cellceutix Prepares Phase 2a Ovarian Cancer Trial of Kevetrin, a Novel p53-Modulating Drug Candidate, Based Upon Phase 1 Topline Data
Sucampo Reports Top-Line Data from Phase 2a Study of Cobiprostone in Patients with PPI-Refractory Non-Erosive Reflux Disease (NERD) and Symptomatic Gastroesophageal Reflux Disease (sGERD)
LaFleur Minerals Engages Maximus Strategic Consulting Inc. for Investor Relations and Marketing Services
West High Yield Resources Receives BC Ministry of Transportation and Transit Access Permit for Record Ridge Magnesium Project and Announces Second Tranche Closing of Private Placement
